SCHEMBL6923607

SCHEMBL6923607

Cc1cc(C(=O)Nc2ccc(OCCn3cccn3)cc2)cc(-c2ccccc2)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.51
MCL1 Q07820 1/20 0.47
PRKAB2 O43741 1/20 0.45
PRKAG1 P54619 1/20 0.45
PRKAA2 P54646 1/20 0.45
PRKAA1 Q13131 1/20 0.45
PRKAG3 Q9UGI9 1/20 0.45
PRKAG2 Q9UGJ0 1/20 0.45
PRKAB1 Q9Y478 1/20 0.45
MAPT P10636 3/20 0.44
CHRNB2 P17787 2/20 0.42
CHRNB4 P30926 2/20 0.42
CHRNA3 P32297 2/20 0.42
CHRNA7 P36544 2/20 0.42
CHRNA4 P43681 2/20 0.42
MCHR1 Q99705 3/20 0.42
NPC1 O15118 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TP53 P04637 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6922965 0.81 THRB (0.48) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6645931 0.78 THRB (0.53) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6645076 0.76 THRB (0.50) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6488813 0.76 MAPT (0.47) MAPTMCHR1NPC1MEN1KMT2A
SCHEMBL6645869 0.75 PRKAB2 (0.50) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6645353 0.74 THRB (0.51) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6645303 0.74 THRB (0.48) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6647724 0.73 THRB (0.48) THRBPRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL6644406 0.72 THRB (0.53) THRBMCL1PRKAB2PRKAG1PRKAA2
SCHEMBL6645791 0.72 THRB (0.52) THRBMCL1PRKAB2PRKAG1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004039795-A2 AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-05-13 WO disclosed